Accretion Pharmaceuticals Limited, a active public limited company, was established on 29 November 2023 in Sanand, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U21004GJ2023PLC146545. Registered under ROC Roc Ahmedabad. it is listed. It has an authorized capital of ₹13.00 Cr and a paid-up capital of ₹11.12 Cr.
In 2024, it reported revenue of ₹13.41 Cr and a net worth of ₹5.49 Cr. Its leadership includes Hardik Mukundbhai Prajapati (Director), Harshad Nanubhai Rathod (Director), Mayur Popatlal Sojitra (Director). Past directors included Vijay Bharatbhai Anadkat, Vivek Ashok Kumar Patel, Shyam Bhadresh Kapadia. It holds ₹10.73 Cr open charges and no settled loans. Its latest AGM occurred on 13 July 2024, with the balance sheet filed on 31 March 2024. It is based at 29 Xcelon Ind Park 1, B/H, Intas Pharmaceuticals, Sanand, Gujarat, 382213.
L21004GJ2023PLC146545
146545
29 November 2023
₹13.00 Cr
₹11.12 Cr
Roc Ahmedabad
Listed
Active
Explore comprehensive insights into Accretion Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hardik Mukundbhai Prajapati | Director | 29 Nov 2023 | Current |
| Harshad Nanubhai Rathod | Director | 29 Nov 2023 | Current |
| Mayur Popatlal Sojitra | Director | 29 Nov 2023 | Current |
| Vivek Ashok Kumar Patel | Managing Director | 29 Nov 2023 | Current |
| Chand Rameshbhai Kanabar | Additional Director | 19 Apr 2025 | Current |
| Grishma A Shewale | Director | 09 Jul 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 12 Jul 2024 | Past |
| Pramod Abcsdd | Director | 08 Jul 2024 | Past |
| Pramod Abcsdd | Additional Director | 12 Jul 2024 | Past |
| Pramod Abcsdd | Additional Director | 12 Jul 2024 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Accretion Pharmaceuticals Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2024, Accretion Pharmaceuticals had a promoter holding of 96.00% and a public holding of 4.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹107,300,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jan 2024 | Indian Bank | ₹10.73 Cr | Open |
Explore comprehensive loan charge details -
Accretion Pharmaceuticals has a workforce of 0 employees as of Oct 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Accretion Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accretion Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Roshni Dharmendrabhai Shah was appointed as a Company Secretary was appointed as a Company Secretary on 27 Sep 2025 & has been associated with this company since 2 months 7 days . was recorded as a recent event.
Nishtha Harivanshi Pamnani was appointed as a Additional Director was appointed as a Additional Director on 10 Jun 2025 & has been associated with this company since 5 months 24 days . was recorded as a recent event.
The activity Chand Rameshbhai Kanabar was appointed as a Additional Director was appointed as a Additional Director on 19 Apr 2025 & has been associated with this company since 7 months 15 days . was completed.
Progress on A charge with Indian Bank of Rs. 10.73 Cr registered on 05 Jan 2024 with Charge ID 100844260 was modified on 13 Dec 2024. was documented.
Harshad Nanubhai Rathod was appointed as a Cfo was appointed as a Cfo on 26 Jul 2024 & has been associated with this company since 1 year 4 months . was recorded as a recent event.
Progress on Accretion Pharmaceuticals Limited last Annual general meeting of members was held on 13 Jul 2024 as per latest MCA records. was documented.
The CIN of Accretion Pharmaceuticals Limited is L21004GJ2023PLC146545.
Accretion Pharmaceuticals Limited is headquartered at 29 Xcelon Ind Park 1, B/H, Intas Pharmaceuticals, Sanand, Gujarat, 382213.
Accretion Pharmaceuticals Limited was incorporated on 29 November 2023.
The current directors of Accretion Pharmaceuticals Limited are
The primary industry of Accretion Pharmaceuticals Limited is Manufacturing.
Accretion Pharmaceuticals Limited is listed.
The authorized capital of Accretion Pharmaceuticals Limited is ₹13.00 Cr, and the paid-up capital is ₹11.12 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX